ID   HeLa 229
AC   CVCL_1276
SY   HeLa-229; HeLa229
DR   BTO; BTO:0005030
DR   CLO; CLO_0003685
DR   CLO; CLO_0003698
DR   CLDB; cl1604
DR   CLDB; cl1605
DR   CLDB; cl1606
DR   ATCC; CCL-2.1
DR   BCRC; 60290
DR   CCRID; 1101HUM-PUMC000181
DR   CCRID; 3101HUMTCHu20
DR   CCRID; 4201HUM-CCTCC00335
DR   CCTCC; GDC0335
DR   ChEMBL-Cells; CHEMBL4483175
DR   ChEMBL-Targets; CHEMBL4483246
DR   CLS; 305056
DR   ECACC; 86090201
DR   IZSLER; BS TCL 21
DR   JCRB; JCRB9086
DR   KCLB; 10002.1
DR   PubChem_Cell_line; CVCL_1276
DR   Wikidata; Q54882513
RX   DOI=10.1007/BF02618370;
RX   DOI=10.11418/jtca1981.17.3_101;
RX   PubMed=1522048;
RX   PubMed=2754009;
RX   PubMed=14185313;
WW   https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-158.html
CC   Population: African American.
CC   Doubling time: 11 hours (Note=Lot 032792), ~26 hours (Note=Lot 03152010) (JCRB=JCRB9086).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-2.1; CCRID; ECACC=86090201; IZSLER=BS TCL 21; JCRB=JCRB9086; KCLB=10002.1
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3 (ATCC=CCL-2.1; CCRID; JCRB=JCRB9086; KCLB=10002.1)
ST   D13S317: 12,14 (IZSLER=BS TCL 21)
ST   D13S317: 14 (ECACC=86090201)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 28
//
RX   DOI=10.1007/BF02618370;
RA   Stulberg C.S., Coriell L.L., Kniazeff A.J., Shannon J.E.;
RT   "The animal cell culture collection.";
RL   In Vitro 5:1-16(1970).
//
RX   DOI=10.11418/jtca1981.17.3_101;
RA   Itami C., Ishida R., Utsumi K.R., Nakabayashi T.;
RT   "Variation in three groups of HeLa cell sublines as revealed by
RT   karyotype analysis and O6-methylguaninedna-methyltransferase
RT   activity.";
RL   Tissue Cult. Res. Commun. 17:101-106(1998).
//
RX   PubMed=1522048; DOI=10.1007/BF02634140;
RA   Kataoka E., Honma M., Ohnishi K., Sofuni T., Mizusawa H.;
RT   "Application of highly polymorphic DNA markers to the identification
RT   of HeLa cell sublines.";
RL   In Vitro Cell. Dev. Biol. Anim. 28:553-556(1992).
//
RX   PubMed=2754009; DOI=10.1128/jcm.27.6.1399-1400.1989;
RA   Thewessen E.A.P.M., Freundt I., van Rijsoort-Vos J.H., Stolz E.,
RA   Michel M.F., Wagenvoort J.H.T.;
RT   "Comparison of HeLa 229 and McCoy cell cultures for detection of
RT   Chlamydia trachomatis in clinical specimens.";
RL   J. Clin. Microbiol. 27:1399-1400(1989).
//
RX   PubMed=14185313; DOI=10.1126/science.146.3641.241;
RG   Cell Culture Collection Committee;
RT   "Animal cell strains. The Cell Culture Collection Committee has
RT   assembled and certified 23 strains of animal cells.";
RL   Science 146:241-243(1964).
//